Creative Planning Anavex Life Sciences Corp. Transaction History

Creative Planning

$116 Billion
Q2 2025

A detailed history of Creative Planning transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Creative Planning holds 58,916 shares of AVXL stock, worth $530,833. This represents 0.0% of its overall portfolio holdings.

Number of Shares

58,916

Previous 50,403 16.89%

Holding current value

$530,833

Previous $432,000 25.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$7.37 - $9.63 $62,740 - $81,980	8,513 Added 16.89%	58,916 $543,000
Q1 2025 May 15, 2025	BUY	$7.85 - $13.46 $50,656 - $86,857	6,453 Added 14.68%	50,403 $432,000
Q4 2024 Feb 14, 2025	BUY	$5.11 - $12.56 $20,843 - $51,232	4,079 Added 10.23%	43,950 $472,000
Q3 2024 Oct 11, 2024	BUY	$4.11 - $7.04 $57,581 - $98,630	14,010 Added 54.17%	39,871 $226,000
Q2 2024 Aug 15, 2024	BUY	$3.39 - $5.02 $5,864 - $8,684	1,730 Added 7.17%	25,861 $109,000
Q1 2024 May 10, 2024	BUY	$4.55 - $6.75 $25,370 - $37,638	5,576 Added 30.05%	24,131 $122,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $34,161 - $67,441	6,778 Added 57.55%	18,555 $172,000
Q3 2023 Nov 16, 2023	SELL	$6.55 - $9.37 $7,591 - $10,859	-1,159 Reduced 8.96%	11,777 $77,000
Q2 2023 Jul 21, 2023	SELL	$7.66 - $9.5 $1,363 - $1,691	-178 Reduced 1.36%	12,936 $105,000
Q1 2023 May 15, 2023	SELL	$8.32 - $11.75 $5,724 - $8,084	-688 Reduced 4.98%	13,114 $112,000
Q4 2022 Feb 10, 2023	SELL	$7.65 - $14.43 $46,764 - $88,210	-6,113 Reduced 30.7%	13,802 $127,000
Q3 2022 Nov 03, 2022	SELL	$8.9 - $12.86 $142,400 - $205,760	-16,000 Reduced 44.55%	19,915 $206,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $12.84 $19,737 - $34,668	2,700 Added 8.13%	35,915 $360,000
Q1 2022 May 16, 2022	BUY	$9.74 - $17.69 $123,698 - $224,663	12,700 Added 61.91%	33,215 $409,000
Q4 2021 Feb 11, 2022	BUY	$16.88 - $23.31 $346,293 - $478,204	20,515 New	20,515 $356,000
Q2 2021 Aug 04, 2021	SELL	$10.16 - $28.86 $180,340 - $512,265	-17,750 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$5.17 - $16.13 $91,767 - $286,307	17,750 New	17,750 $265,000

Others Institutions Holding AVXL

# of Institutions

196

Shares Held

32M

Call Options Held

1.16M

Put Options Held

804K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $702M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Anavex Life Sciences Corp. Transaction History